Tsukuba, Japan

Shinya Okubo

This inventor holds 1 USPTO granted patent. Top assignee: Eisai R&D Management Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinya Okubo. Retrieved from https://idiyas.com/inventor/shinya-okubo-o9lv8drn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shinya Okubo: Innovator in Antibody-Drug Conjugates

Introduction

Shinya Okubo is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. His innovative work has the potential to enhance therapeutic options for various diseases.

Latest Patents

Shinya Okubo holds a patent for "HERBOXIDIENE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE." This patent represents a significant advancement in targeted drug delivery systems, which can improve the efficacy and reduce the side effects of cancer treatments.

Career Highlights

Okubo is currently associated with Eisai R&D Management Co., Ltd., where he continues to push the boundaries of medical research and innovation. His work is characterized by a commitment to improving patient outcomes through advanced therapeutic strategies.

Collaborations

Throughout his career, Shinya Okubo has collaborated with notable colleagues, including Nathan Fishkin and Thiwanka Samarakoon. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Shinya Okubo's contributions to the field of antibody-drug conjugates exemplify the impact of innovative thinking in biotechnology. His work not only advances scientific knowledge but also holds promise for improving treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…